Helen Diller Family Comprehensive Cancer Center, Cancer Research Institute, University of California San Francisco, San Francisco, California, United States of America.
PLoS One. 2012;7(2):e31301. doi: 10.1371/journal.pone.0031301. Epub 2012 Feb 13.
Genome-wide association studies (GWAS) have been successful in finding associations between specific genetic variants and cancer susceptibility in human populations. These studies have identified a range of highly statistically significant associations between single nucleotide polymorphisms (SNPs) and susceptibility to development of a range of human tumors. However, the effect of each SNP in isolation is very small, and all of the SNPs combined only account for a relatively minor proportion of the total genetic risk (5-10%). There is therefore a major requirement for alternative routes to the discovery of genetic risk factors for cancer. We have previously shown using mouse models that chromosomal regions harboring susceptibility genes identified by linkage analysis frequently exhibit allele-specific genetic alterations in tumors. We demonstrate here that the Fbxw7 gene, a commonly mutated gene in a wide range of mouse and human cancers, shows allele-specific deletions in mouse lymphomas and skin tumors. Lymphomas from three different F1 hybrids show 100% allele-specificity in the patterns of allelic loss. Parental alleles from 129/Sv or Spretus/Gla mice are lost in tumors from F1 hybrids with C57BL/6 animals, due to the presence of a specific non-synonymous coding sequence polymorphism at the N-terminal portion of the gene. A specific genetic test of association between this SNP and lymphoma susceptibility in interspecific backcross mice showed a significant linkage (p = 0.001), but only in animals with a functional p53 gene. These data therefore identify Fbxw7 as a p53-dependent tumor susceptibility gene. Increased p53-dependent tumor susceptibility and allele-specific losses were also seen in a mouse skin model of skin tumor development. We propose that analysis of preferential allelic imbalances in tumors may provide an efficient means of uncovering genetic variants that affect mouse and human tumor susceptibility.
全基因组关联研究(GWAS)已成功发现人类群体中特定遗传变异与癌症易感性之间的关联。这些研究已经确定了一系列高度统计学意义上的单核苷酸多态性(SNP)与一系列人类肿瘤发生易感性之间的关联。然而,每个 SNP 单独的作用非常小,所有 SNP 加起来仅占总遗传风险的相对较小比例(5-10%)。因此,需要寻找癌症遗传风险因素的替代途径。我们之前已经使用小鼠模型表明,通过连锁分析确定的易感基因所在的染色体区域在肿瘤中经常表现出等位基因特异性的遗传改变。我们在这里证明,Fbxw7 基因是广泛存在于小鼠和人类癌症中的常见突变基因,在小鼠淋巴瘤和皮肤肿瘤中表现出等位基因特异性缺失。来自三种不同 F1 杂交种的淋巴瘤在等位基因丢失模式上表现出 100%的等位基因特异性。来自 129/Sv 或 Spretus/Gla 小鼠的亲本等位基因由于基因 N 端部分存在特定的非编码序列多态性而在 F1 杂交种的肿瘤中丢失,而 C57BL/6 动物的等位基因丢失。该 SNP 与种间回交小鼠淋巴瘤易感性之间的特定关联遗传测试显示出显著的连锁(p = 0.001),但仅在具有功能性 p53 基因的动物中。因此,这些数据将 Fbxw7 鉴定为一种依赖 p53 的肿瘤易感性基因。在小鼠皮肤肿瘤发展的皮肤模型中也观察到了依赖 p53 的肿瘤易感性增加和等位基因特异性缺失。我们提出,分析肿瘤中优先等位基因失衡可能是揭示影响小鼠和人类肿瘤易感性的遗传变异的有效方法。